Registered entities
Mnemosyne Pharmaceuticals Inc
Reg. No. 272199067United States
Innovation
13 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,216 times.
| Year | Filings |
|---|---|
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 2 |
Investor mix
8 investors on record; lead investors include Cowen, Atlas Venture.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Bank & private debt | 2 | 25% |
| Other / undisclosed | 1 | 13% |